Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis.
D000328:Adult; D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D001803:Blood Transfusion; D002986:Clinical Trials as Topic; D004906:Erythrocyte Count; D006400:Hematocrit; D006437:Hemodialysis, Home / Q000009:adverse effects; D006452:Hemoglobinometry; D006801:Humans; D007273:Injections, Intramuscular; D007501:Iron / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009277:Nandrolone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011446:Prospective Studies; D006435:Renal Dialysis / Q000009:adverse effects*; D012156:Reticulocytes; D013997:Time Factors
D010919:Placebos; D009277:Nandrolone; D007501:Iron